The expression of CD44, CD104, LMP1, and LMP2A in NPC clinical samples were analyzed by IHC assay and results showed that all three cases expressed LMP1, CD44, CD104, while only case 1 expressed a low level of LMP2A (Fig 5I). The gene discussed is CD44; the disease is nasopharyngeal carcinoma.